These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11799630)

  • 1. Monoclonal antibodies in the immunotherapy of autoimmune diseases.
    Perosa F; Luccarelli G; Prete M; Dammacco F
    Ann Ital Med Int; 2001; 16(4):220-32. PubMed ID: 11799630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.
    Prete M; Perosa F; Favoino E; Dammacco F
    Clin Exp Med; 2005 Dec; 5(4):141-60. PubMed ID: 16362794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Dammacco F
    Ann N Y Acad Sci; 2005 Jun; 1051():672-83. PubMed ID: 16127008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Luccarelli G; Indiveri F
    Clin Exp Rheumatol; 1997; 15(2):201-10. PubMed ID: 9196876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the functional characteristics of antibodies to therapeutic anti-human tumor necrosis factor alpha monoclonal antibody.
    Yucel A; Aral AL; Basturk B; Karakus R; Aybay C; Aybay C
    Immunol Lett; 2007 Aug; 111(2):84-91. PubMed ID: 17618693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-class II antibody treatment in autoimmune diseases.
    Boitard C
    Immunol Ser; 1993; 59():279-93. PubMed ID: 8461393
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapeutic approaches with monoclonal antibodies to immunological diseases.
    Cozzi E; Ferrone S
    Recenti Prog Med; 1992 Sep; 83(9):528-33. PubMed ID: 1439123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the development of therapeutic anti-cytokine antibodies.
    Reichert JM
    Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice].
    Yuan J; Liao YH; Wang ZH; Cheng X; Zhang JH; Dong JH; Wang M
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3346-9. PubMed ID: 16409842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.